- Home
- DOYU vs OSUR Comparison
DOYU vs OSUR Comparison
Compare DOYU & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOYU
- OSUR
- Stock Information
- Founded
- DOYU 2014
- OSUR 2000
- Country
- DOYU China
- OSUR United States
- Employees
- DOYU N/A
- OSUR N/A
- Industry
- DOYU Computer Software: Programming Data Processing
- OSUR Medical/Dental Instruments
- Sector
- DOYU Technology
- OSUR Health Care
- Exchange
- DOYU Nasdaq
- OSUR Nasdaq
- Market Cap
- DOYU 195.9M
- OSUR 228.1M
- IPO Year
- DOYU 2019
- OSUR 1986
- Fundamental
- Price
- DOYU $7.86
- OSUR $3.01
- Analyst Decision
- DOYU Hold
- OSUR Hold
- Analyst Count
- DOYU 1
- OSUR 1
- Target Price
- DOYU $7.00
- OSUR $3.00
- AVG Volume (30 Days)
- DOYU 78.5K
- OSUR 738.4K
- Earning Date
- DOYU 09-11-2025
- OSUR 08-05-2025
- Dividend Yield
- DOYU 249.36%
- OSUR N/A
- EPS Growth
- DOYU N/A
- OSUR N/A
- EPS
- DOYU N/A
- OSUR N/A
- Revenue
- DOYU $575,786,186.00
- OSUR $161,626,000.00
- Revenue This Year
- DOYU N/A
- OSUR N/A
- Revenue Next Year
- DOYU N/A
- OSUR $6.80
- P/E Ratio
- DOYU N/A
- OSUR N/A
- Revenue Growth
- DOYU N/A
- OSUR N/A
- 52 Week Low
- DOYU $5.68
- OSUR $2.36
- 52 Week High
- DOYU $20.17
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- DOYU 48.90
- OSUR 42.25
- Support Level
- DOYU $8.45
- OSUR $3.25
- Resistance Level
- DOYU $9.34
- OSUR $3.51
- Average True Range (ATR)
- DOYU 0.51
- OSUR 0.14
- MACD
- DOYU -0.04
- OSUR -0.03
- Stochastic Oscillator
- DOYU 12.13
- OSUR 1.96
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.